tradingkey.logo

SelectQuote Inc

SLQT

2.030USD

+0.025+1.25%
Close 09/26, 16:00ETQuotes delayed by 15 min
350.82MMarket Cap
14.01P/E TTM

SelectQuote Inc

2.030

+0.025+1.25%
More Details of Company
Company Info
Ticker SymbolSLQT
Company nameSelectQuote Inc
IPO dateMay 21, 2020
CEOMr. Timothy Robert (Tim) Danker
Number of employees- -
Security typeOrdinary Share
Fiscal year-endMay 21
Address6800 West 115Th Street
CityOVERLAND PARK
Stock exchangeNYSE Consolidated
CountryUnited States of America
Postal code66211
Phone19132741994
Websitehttps://ir.selectquote.com/investor-home/default.aspx
Ticker SymbolSLQT
IPO dateMay 21, 2020
CEOMr. Timothy Robert (Tim) Danker
Company Executives
Name
Name/Position
Position
Shareholding
Change
Mr. Robert Clay (Bob) Grant
Mr. Robert Clay (Bob) Grant
President
President
4.32M
+10.97%
Mr. Timothy Robert (Tim) Danker
Mr. Timothy Robert (Tim) Danker
Chief Executive Officer, Director
Chief Executive Officer, Director
2.63M
+21.12%
Ms. Denise L. Devine, CPA
Ms. Denise L. Devine, CPA
Independent Director
Independent Director
318.58K
+1.27%
Dr. Kavita K. Patel, M.D.
Dr. Kavita K. Patel, M.D.
Independent Director
Independent Director
310.58K
+43.99%
Mr. Ryan Moore Clement
Mr. Ryan Moore Clement
Chief Financial Officer
Chief Financial Officer
304.70K
+95.99%
Ms. Sarah Anderson
Ms. Sarah Anderson
Executive Vice President - Pharmacy Services
Executive Vice President - Pharmacy Services
51.63K
+586.59%
Mr. Sloan Bohlen
Mr. Sloan Bohlen
Investor Relations
Investor Relations
--
--
Mr. William Thomas Grant, III
Mr. William Thomas Grant, III
Chief Operating Officer
Chief Operating Officer
--
--
Ms. Stephanie D. Fisher
Ms. Stephanie D. Fisher
Chief Accounting Officer
Chief Accounting Officer
--
--
Mr. Raymond F. Weldon
Mr. Raymond F. Weldon
Independent Director
Independent Director
--
--
View more
Name
Name/Position
Position
Shareholding
Change
Mr. Robert Clay (Bob) Grant
Mr. Robert Clay (Bob) Grant
President
President
4.32M
+10.97%
Mr. Timothy Robert (Tim) Danker
Mr. Timothy Robert (Tim) Danker
Chief Executive Officer, Director
Chief Executive Officer, Director
2.63M
+21.12%
Ms. Denise L. Devine, CPA
Ms. Denise L. Devine, CPA
Independent Director
Independent Director
318.58K
+1.27%
Dr. Kavita K. Patel, M.D.
Dr. Kavita K. Patel, M.D.
Independent Director
Independent Director
310.58K
+43.99%
Mr. Ryan Moore Clement
Mr. Ryan Moore Clement
Chief Financial Officer
Chief Financial Officer
304.70K
+95.99%
Ms. Sarah Anderson
Ms. Sarah Anderson
Executive Vice President - Pharmacy Services
Executive Vice President - Pharmacy Services
51.63K
+586.59%
Revenue Breakdown
Currency: USDUpdated: Sun, Jul 6
Currency: USDUpdated: Sun, Jul 6
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2021
FY2020
FY2019
By BusinessUSD
Name
Revenue
Proportion
Commission
193.16M
47.32%
Pharmacy revenue
185.27M
45.39%
Production bonus and other revenue
29.73M
7.28%
No Data
By Business
By Region
By BusinessUSD
Name
Revenue
Proportion
Commission
193.16M
47.32%
Pharmacy revenue
185.27M
45.39%
Production bonus and other revenue
29.73M
7.28%
Shareholding Stats
Updated: Sat, Aug 16
Updated: Sat, Aug 16
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
Brookside Equity Partners LLC
10.23%
BlackRock Institutional Trust Company, N.A.
5.33%
The Vanguard Group, Inc.
4.75%
Abrams Bison Investments, L.L.C.
4.58%
Mariner Wealth Advisors
3.68%
Other
71.43%
Shareholders
Shareholders
Proportion
Brookside Equity Partners LLC
10.23%
BlackRock Institutional Trust Company, N.A.
5.33%
The Vanguard Group, Inc.
4.75%
Abrams Bison Investments, L.L.C.
4.58%
Mariner Wealth Advisors
3.68%
Other
71.43%
Shareholder Types
Shareholders
Proportion
Investment Advisor
20.81%
Investment Advisor/Hedge Fund
14.55%
Individual Investor
11.53%
Private Equity
10.23%
Hedge Fund
6.83%
Research Firm
1.79%
Corporation
0.63%
Pension Fund
0.45%
Bank and Trust
0.38%
Other
32.81%
Institutional Shareholding
Updated: Tue, Aug 5
Updated: Tue, Aug 5
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2025Q2
332
110.44M
63.96%
+4.81M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
No Data
View more
Related ETFs
Updated: Sat, Sep 6
Updated: Sat, Sep 6
Name
Proportion
ProShares Hedge Replication ETF
0.01%
Dimensional US Core Equity 1 ETF
0%
Global X Russell 2000 Covered Call ETF
0%
iShares FinTech Active ETF
0%
DFA Dimensional US Small Cap Value ETF
0%
Fidelity MSCI Financials Index ETF
0%
Vanguard US Momentum Factor ETF
0%
ProShares Hedge Replication ETF
Proportion0.01%
Dimensional US Core Equity 1 ETF
Proportion0%
Global X Russell 2000 Covered Call ETF
Proportion0%
iShares FinTech Active ETF
Proportion0%
DFA Dimensional US Small Cap Value ETF
Proportion0%
Fidelity MSCI Financials Index ETF
Proportion0%
Vanguard US Momentum Factor ETF
Proportion0%
Dividend
A total of 0.00 USD has been distributed in dividends over the past 5 years.
Date
Dividend
Record Date
Payment Date
Ex-dividend Date
No Data
Stock Split
Date
Type
Ratio
No Data
Date
Type
Ratio
No Data
KeyAI